A client is post-op nephrectomy for renal cancer. Which lab results would cause most concern for the nurse?
Table 34.1 Review of Normal Ranges for Complete Blood Cell Counts (Adult)
|
Blood Cell |
Normal Ranges |
|
Red blood cells (mature, circulating) |
Male 4.51-6.01 million/mm3 Female: 4.01-5.51 million/mm3 |
|
Hemoglobin |
Adult (15-64 yr) Male 14-17.3 g/dL Female 11.7-15.5 g/dL |
|
Hematocrit |
42% -52% in males 36% -48% in females |
|
Reticulocytes |
0.5% -2.5% of total RBC count |
|
White blood cells (total) |
4.5-11.1 103/mm3 |
|
Neutrophils |
59% Bands 3% Segs-56% |
|
Eosinophils |
2.7% |
|
Basophils |
0.5% |
|
Lymphocytes |
34% |
|
Monocytes |
4% |
|
Platelets |
150,000-450,000/mm3 |
Hemoglobin of 14 g/dL
Platelet count 150,000 mm3
White blood cell count 17,000 mm3
Neutrophils 59%
The Correct Answer is C
A. This value is within the normal range for adult males (14-17.3 g/dL) and borderline for females (11.7- 15.5 g/dL). While the specific context of the patient (e.g., gender) matters, generally, a hemoglobin level of 14 g/dL would not typically cause concern.
B. A platelet count of 150,000/mm³ is at the lower limit of normal (150,000-450,000/mm³). While this may be concerning in certain clinical contexts, it is still within the acceptable range and would not typically raise alarm for a post-op nephrectomy patient unless there are other indications of bleeding or clotting issues.
C. This white blood cell count is elevated (normal range is 4.5-11.1 x 10³/mm³). An elevated WBC count can indicate an infection, inflammation, or a response to surgery, which is particularly concerning post- operatively. This result would warrant further investigation to rule out infection, which is critical for recovery.
D. The neutrophil percentage of 59% is within the normal range (typically around 40-70% for total WBCs). While it is slightly elevated, it is not concerning on its own without additional context, especially since it may be elevated in response to surgery or stress.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is C
Explanation
A. While it is true that some cancers of the reproductive tract can be slow-growing and may respond well to treatment, this statement is overly generalized. It does not specifically address the prognosis or treatment success associated with cervical carcinoma in situ.
B. This statement provides a statistic but may not accurately reflect the prognosis for cervical carcinoma in situ, which is typically higher than 75% when detected and treated early. This response could also imply that the survival rate for invasive cervical cancer is the same, which could lead to misunderstanding.
C. Cervical carcinoma in situ is a pre-invasive stage of cervical cancer, and when it is detected early, the treatment is usually very effective, leading to a high cure rate. This statement reassures the husband that the prognosis is good, given that early detection and treatment are key factors.
D. The term "curable" implies a much better prognosis than a mere 50% survival rate, which may refer to various cancers and does not specifically apply to cervical carcinoma in situ. This response does not provide the husband with the clarity he needs about his wife's condition.
Correct Answer is C
Explanation
A. Warfarin is an anticoagulant used to prevent blood clots. While it may be prescribed for certain patients at risk for stroke, it is not typically the first-line medication for managing TIA or hyperlipidemia. It is more often used in patients with specific types of atrial fibrillation or mechanical heart valves.
B. Simethicone is an anti-foaming agent used to relieve gas and bloating. It does not have any role in managing hyperlipidemia or preventing strokes. Thus, this option is not relevant to the client's condition.
C. Simvastatin is a statin medication used to lower cholesterol levels and reduce the risk of cardiovascular events, including stroke. For a client with hyperlipidemia and a history of TIA, simvastatin would be an appropriate medication to help manage cholesterol and decrease the risk of future ischemic events.
D. Enoxaparin is a low-molecular-weight heparin used for anticoagulation, often in the context of deep vein thrombosis or pulmonary embolism. It may not be the first choice for TIA management. While it has its uses in preventing clot formation, it is not the standard treatment for a patient who has had a TIA.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.
